Skip to main content
You are browsing the curriculum of a past academic year (2022–2023).
Do you want to change to the ongoing academic year?
Course unit, curriculum year 2022–2023
BBT.MJS.147

Health Technology and Life Science R&D, 5 cr

Tampere University
Teaching periods
Active in period 3 (1.1.2023–5.3.2023)
Active in period 4 (6.3.2023–31.5.2023)
Course code
BBT.MJS.147
Language of instruction
English
Academic years
2021–2022, 2022–2023, 2023–2024
Level of study
Advanced studies
Grading scale
Pass-Fail
Persons responsible
Responsible teacher:
Juho Väisänen until 19.6.2023
Responsible teacher:
Helena Lähdekorpi starting from 20.6.2023
Responsible organisation
Faculty of Medicine and Health Technology 100 %
Coordinating organisation
MET Studies 100 %
Common learning outcomes
International outlook and global responsibility
Core content
  • Product development process
  • Product market fit
  • Design thinking in R&D projects
  • IPR issues
  • Regulation and quality
  • Proof-of-concept and relevance
  • Clinical trials
  • Project and process management
  • Manufacturing (CMC) considerations
Complementary knowledge
  • Goal is to provide insights to the medical technology product as well as drug development process. The participants will understand the basic principles and key elements required in developing new products and drugs.
  • Goal is to provide understanding how the markets and unmet needs affect the R&D in life science and the importance of product market fit. The participants will understand the how to assess and explore product market fit and how the information is applied in R&D process.
  • Goal is to provide introduce design thinking principles and especially how these can be applied in efficiently life science R&D projects. The participants will understand the how, where and when to apply design thinking principles.
  • Goal is to provide understanding of intellectual property rights and their protection. The participants will understand the basic mechanisms of IP protection and how these affect the life science R&D and business.
  • Goal is to provide basic information related to regulatory and quality issues affecting the medical technology product and drug development processes. The participants will understand which authorities and regulations affect the R&D and how these should be taken into account in development process.
  • Goal is to provide basic information of proof-of concept and relevance in R&D. The participants will understand the importance of POC and POR.
  • Goal is to provide understanding of clinical trial process as part of the life science R&D. The participants will understand different phases of pre-clinical and clinical trial process as well as how these affect the whole R&D process.
  • Goal is to provide understanding of importance of project and process management in life science R&D. The participants will understand different phases and methods related to project and process management.
  • Goal is to provide insights to manufacturing related to the life science R&D. The participants will understand how the manufacturing affects the whole R&D process.
Learning outcomes
Further information
Studies that include this course
Completion option 1
approved learning diary and assignment

Participation in teaching

17.01.2023 30.04.2023
Active in period 3 (1.1.2023–5.3.2023)
Active in period 4 (6.3.2023–31.5.2023)